nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
|
Yamout, Hala |
|
2014 |
21 |
3 |
p. 281-286 6 p. |
artikel |
2 |
Cardiovascular Complications of Diabetic Kidney Disease
|
Pálsson, Ragnar |
|
2014 |
21 |
3 |
p. 273-280 8 p. |
artikel |
3 |
Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole
|
Yee, Jerry |
|
2014 |
21 |
3 |
p. 251-255 5 p. |
artikel |
4 |
Editorial Board
|
|
|
2014 |
21 |
3 |
p. A1- 1 p. |
artikel |
5 |
Epidemiology and Risk Factors for Diabetic Kidney Disease
|
Harjutsalo, Valma |
|
2014 |
21 |
3 |
p. 260-266 7 p. |
artikel |
6 |
Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
|
McKnight, Amy Jayne |
|
2014 |
21 |
3 |
p. 287-296 10 p. |
artikel |
7 |
Glomerular and Tubular Function in the Diabetic Kidney
|
Blantz, Roland C. |
|
2014 |
21 |
3 |
p. 297-303 7 p. |
artikel |
8 |
Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications
|
Thomas, Merlin C. |
|
2014 |
21 |
3 |
p. 311-317 7 p. |
artikel |
9 |
Masthead
|
|
|
2014 |
21 |
3 |
p. IFC- 1 p. |
artikel |
10 |
Natural History and Clinical Characteristics of CKD in Type 1 and Type 2 Diabetes Mellitus
|
Marshall, Sally M. |
|
2014 |
21 |
3 |
p. 267-272 6 p. |
artikel |
11 |
New Insights Into the Use of Biomarkers of Diabetic Nephropathy
|
Jha, Jay C. |
|
2014 |
21 |
3 |
p. 318-326 9 p. |
artikel |
12 |
Podocytes, Signaling Pathways, and Vascular Factors in Diabetic Kidney Disease
|
Brosius, Frank C. |
|
2014 |
21 |
3 |
p. 304-310 7 p. |
artikel |
13 |
Table of Contents
|
|
|
2014 |
21 |
3 |
p. A3-A4 nvt p. |
artikel |
14 |
The Changing Landscape of Diabetic Kidney Disease: New Reflections on Phenotype, Classification, and Disease Progression to Influence Future Investigative Studies and Therapeutic Trials
|
Ho, Kevin |
|
2014 |
21 |
3 |
p. 256-259 4 p. |
artikel |